AdvertisementA Cancer Drug For Parkinson's? New Study Raises Hope, Draws Criticism02:59Download AudioResumeDecember 16, 2019Jon HamiltonfacebookEmailA study finds some evidence that a cancer drug, nilotinib, may help people with Parkinson's disease, a nervous system disorder that causes movement problems. It possibly works by raising levels of dopamine, the brain chemical that is lacking in people with the disease. (Science Source)